Federal Register / Vol. 62, No. 225 / Friday, November 21, 1997 / Notices 62349

Michigan, and 13 addition

municipalities that send wastewater to

the Wayne’s Treatment Plant (the

‘‘Plant’’). The case was resolved in 1994

by a Consent Decree pursuant to which

defendants agreed to attain and

maintain compliance with the Plant’s

National Pollutant Discharge

Elimination System permit limits and to

comply with Decree-mandated interim

limits during construction of Plant and

collection-system improvements.

Defendants further agreed to complete

capital improvements needed at the

Plant and in its collection system. The

capital-improvements project, detailed

in a 1993 Project Plan incorporated by

reference in the 1994 Decree, included

steps to achieve: the removal of

improper infiltration-and-inflow; the

improvement of transport and storage

capacity in the Plant’s wastewater

collection system by constructing

retention-equalization basins and an

underground tunnel for storage and

transport of untreated wastewater; and

the upgrade the Plant’s facilities to

ensure that all flows meet Permitmandated limits.

Since entry of the Consent Decree in

1994, defendants have submitted

studies, plans, and design documents

required by the 1994 Consent Decree to

the U.S. Environmental Protection

Agency and the Michigan Department of

Environmental Quality. These

documents contain recommendations

for changes in the design of certain

components of the work required by the

1994 Consent Decree, including: the

modification of the wastewater storage

and transport tunnel required by the

original decree; further improvements in

Plant treatment capacity; further study

and design work prior to

commencement of construction of a

detention basin required by the 1994

Decree, referred to as the Eureka Basin,

intended to eliminate sewer overflows

and backups in the Plant’s collection

system above the proposed basin; and

construction of a new connecting

conduit, rather than a new Plant outfall,

that would convey excess flows from

the Plant to another treatment plant for

treatment and discharge. The

Amendment, if approved by the Court,

would modify the injunctive relief

provisions of the 1994 Decree to reflect

these changes to the 1993 Project Plan.

In all other respects, the 1994 Decree

would remain the same.

The Department of Justice will receive

for a period of thirty (30) days from the

date of this publication comments

relating to the Amendment. Comments

should be addressed to the Assistant

Attorney General of the Environment

and Natural Resources Division,

Department of Justice, Washington, DC

20530, and should refer to United States

and State of Michigan v. Wayne County

et al., D.J. Ref. 90–5–1–1–2766.

The Amendment may be examined at

the Office of the United States Attorney,

Eastern District of Michigan, 211 W.

Fort Street, Suite 2300, Detroit, MI

48226, at U.S. EPA Region 5, 77 West

Jackson Blvd., Chicago, Illinois, 60604,

and at the Consent Decree Library, 1120

G Street, NW., 4th Floor, Washington,

DC 20005, (202) 624–0892. A copy of

the Amendment may be obtained in

person or by mail from the Consent

Decree Library, 1120 G Street, NW., 4th

Floor, Washington, DC 20005. In

requesting a copy, please enclose a

check in the amount of $8.50 (25 cents

per page reproduction cost) payable to

the Consent Decree Library.

Joel M. Gross,

Chief, Environmental Enforcement Section,

Environment and Natural Resources Division.

[FR Doc. 97–30588 Filed 11–20–97; 8:45 am]

BILLING CODE 4410–15–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[DEA #167F]

Controlled Substances: Established

Initial Aggregate Production Quotas

for 1998

AGENCY: Drug Enforcement

Administration (DEA), Justice.

ACTION: Notice of aggregate production

quotas for 1998.

SUMMARY: This notice establishes initial

1998 aggregate production quotas for

controlled substances in Schedules I

and II of the Controlled Substances Act.

EFFECTIVE DATE: November 21, 1997.

FOR FURTHER INFORMATION CONTACT:

Frank L. Sapienza, Chief, Drug &

Chemical Evaluation Section, Drug

Enforcement Administration,

Washington, DC 20537, Telephone:

(202) 307–7183.

SUPPLEMENTARY INFORMATION: Section

306 of the Controlled Substances Act

(21 U.S.C. 826) requires that the

Attorney General establish aggregate

production quotas for each basic class of

controlled substance listed in Schedules

I and II. This responsibility has been

delegated to the Administrator of the

DEA by Section 0.100 of Title 28 of the

Code of Federal Regulations. The

Administrator, in turn, has redelegated

this function to the Deputy

Administrator pursuant to Section 0.104

of Title 28 of the Code of Federal

Regulations.

On September 2, 1997, a notice of the

proposed initial 1998 aggregate

production quotas for certain controlled

substances in Schedules I and II was

published in the Federal Register (62

FR 46373). All interested persons were

invited to comment on or object to these

proposed aggregate production quotas

on or before October 2, 1997.

One company commented that the

initial 1998 aggregate production quota

for amphetamine is insufficient to

provide for the estimated medical,

scientific, research and industrial needs

of the United States, for export

requirements and for the establishment

and maintenance of reserve stocks.

Another company commented that

the initial 1998 aggregate production

quotas for codeine (for sale),

diphenoxylate, morphine (for sale),

opium, and oxycodone (for sale) are

insufficient to provide for the estimated

medical, scientific, research and

industrial needs of the United States, for

export requirements and for the

establishment and maintenance of

reserve stocks.

After a review of 1997 manufacturing

quotas, current 1997 sales and

inventories, 1998 export requirements

and research and product development

requirements, the DEA agrees that

increases are necessary for

amphetamine, codeine (for sale),

morphine (for sale) and oxycodone (for

sale). Regarding diphenoxylate and

opium, the DEA has determined that the

proposed initial 1998 aggregate

production quotas are sufficient to meet

the 1998 estimated medical, scientific,

research and industrial needs of the

United States.

The Office of Management and Budget

has determined that notices of aggregate

production quotas are not subject to

centralized review under Executive

Order 12866. This action has been

analyzed in accordance with the

principles and criteria contained in

Executive Order 12612, and it has been

determined that this matter does not

have sufficient federalism implications

to warrant the preparation of a

Federalism Assessment.

The Acting Deputy Administrator

hereby certifies that this action will

have no significant impact upon small

entities whose interests must be

considered under the Regulatory

Flexibility Act, 5 U.S.C. 601 et seq. The

establishment of aggregate production

quotas for Schedules I and II controlled

substances is mandated by law and by

international treaty obligations.

Aggregate production quotas apply to

approximately 200 DEA registered bulk

and dosage from manufacturers of

Schedules I and II controlled
62350 Federal Register / Vol. 62, No. 225 / Friday, November 21, 1997 / Notices

substances. The quotas are necessary to

provide for the estimated medical,

scientific, research and industrial needs

of the United States, for export

requirements and the establishment and

maintenance of reserve stocks. While

aggregate production quotas are of

primary importance to large

manufacturers, their impact upon small

entities is neither negative nor

beneficial. Accordingly, the Acting

Deputy Administrator has determined

that this action does not require a

regulatory flexibility analysis.

Therefore, under the authority vested

in the Attorney General by Section 306

of the Controlled Substances Act of

1970 (21 U.S.C. 826), delegated to the

Administrator of the DEA by Section

0.100 of Title 28 of the Code of Federal

Regulations, and redelegated to the

Deputy Administrator pursuant to

Section 0.104 of Title 28 of the Code of

Federal Regulations, the Acting Deputy

Administrator hereby orders that the

1998 initial aggregate production quotas

for the following controlled substances,

expressed in grams of anhydrous acid or

base, be established as follows:

Basic class

Established

initial 1998

quotas

Schedule I:

2,5-Dimethoxyamphetamine ............................................................................................................................................................. 15,000,100

2,5-Dimethoxy-4-ethylamphetamine (DOET) ................................................................................................................................... 2

3-Methylfentanyl ................................................................................................................................................................................ 14

3-Methylthiofentanyl .......................................................................................................................................................................... 2

3,4-Methylenedioxyamphetamine (MDA) ......................................................................................................................................... 25

3,4-Methylenedioxy-N-ethylamphetamine (MDEA) .......................................................................................................................... 30

3,4-Methylenedioxymethamphetamine (MDMA) .............................................................................................................................. 20

3,4,5-Trimethoxyamphetamine ......................................................................................................................................................... 2

4-Bromo-2,5,-Dimeththoxyamphetamine .......................................................................................................................................... 2

4-Bromo-2,5-Dimeththoxyphenethylamine (2–CB) ........................................................................................................................... 2

4-Methoxyamphetamine ................................................................................................................................................................... 100,100

4-Methylaminorex ............................................................................................................................................................................. 2

4-Methyl-2,5-Dimethoxyamphetamine (DOM) .................................................................................................................................. 2

5-Methoxy-3,4-Methylenedioxyamphetamine ................................................................................................................................... 2

Acetyl-alpha-methylfentanyl .............................................................................................................................................................. 2

Acetylmethadol ................................................................................................................................................................................. 7

Allylprodine ....................................................................................................................................................................................... 2

Alpha-acetylmethadol ....................................................................................................................................................................... 7

Alpha-ethyltryptamine ....................................................................................................................................................................... 2

Alphameprodine ................................................................................................................................................................................ 2

Alpha-methadol ................................................................................................................................................................................. 2

Alpha-methylfentanyl ........................................................................................................................................................................ 2

Alphaprodine ..................................................................................................................................................................................... 2

Alpha-methylthiofentanyl ................................................................................................................................................................... 2

Aminorex ........................................................................................................................................................................................... 7

Beta-acetylmethadol ......................................................................................................................................................................... 2

Beta-hydroxyfentanyl ........................................................................................................................................................................ 2

Beta-hydroxy-3-methylfentanyl ......................................................................................................................................................... 2

Beta-methadol .................................................................................................................................................................................. 2

Betaprodine ...................................................................................................................................................................................... 2

Bufotenine ......................................................................................................................................................................................... 2

Cathinone ......................................................................................................................................................................................... 9

Codeine-N-oxide ............................................................................................................................................................................... 2

Diethyltryptamine .............................................................................................................................................................................. 2

Difenoxin ........................................................................................................................................................................................... 16,000

Dihydromorphine ............................................................................................................................................................................... 7

Dimethyltryptamine ........................................................................................................................................................................... 2

Ethylamine Analog of PCP ............................................................................................................................................................... 5

Heroin ............................................................................................................................................................................................... 2

Hydroxypethidine .............................................................................................................................................................................. 2

Lysergic acid diethylamide (LSD) ..................................................................................................................................................... 57

Mescaline .......................................................................................................................................................................................... 7

Methaqualone ................................................................................................................................................................................... 17

Methcathinone .................................................................................................................................................................................. 11

Morphine-N-oxide ............................................................................................................................................................................. 2

N-Ethylamphetamine ........................................................................................................................................................................ 7

N-Hydroxy-3,4-Methylenedioxyamphetamine ................................................................................................................................... 4

N,N-Dimethylamphetamine ............................................................................................................................................................... 7

Noracymethadol ................................................................................................................................................................................ 2

Norlevorphanol ................................................................................................................................................................................. 2

Normethadone .................................................................................................................................................................................. 7

Normorphine ..................................................................................................................................................................................... 7

Para-fluorofentanyl ............................................................................................................................................................................ 2

Pholcodine ........................................................................................................................................................................................ 2

Psilocin ............................................................................................................................................................................................. 2

Psilocybin .......................................................................................................................................................................................... 2

Tetrahydrocannabinols ..................................................................................................................................................................... 26,000

Thiofentanyl ...................................................................................................................................................................................... 2

Trimeperidine .................................................................................................................................................................................... 2
Federal Register / Vol. 62, No. 225 / Friday, November 21, 1997 / Notices 62351

Basic class

Established

initial 1998

quotas

Schedule II:

1-Phenylcyclohexylamine ................................................................................................................................................................. 15

1-Piperidinocyclohexanecarbonitrile (PCC) ...................................................................................................................................... 12

Alfentanil ........................................................................................................................................................................................... 8,100

Amobarbital ....................................................................................................................................................................................... 12

Amphetamine .................................................................................................................................................................................... 4,037,000

Cocaine ............................................................................................................................................................................................. 550,100

Codeine (for sale) ............................................................................................................................................................................. 62,020,000

Codeine (for conversion) .................................................................................................................................................................. 18,460,000

Desoxyephedrine .............................................................................................................................................................................. 1,332,000

1,300,000 grams of levodesoxyephedrine for use in a non-controlled, non-prescription product and 32,000 grams for

methamphetamine.

Dextropropoxyphene ......................................................................................................................................................................... 109,500,000

Dihydrocodeine ................................................................................................................................................................................. 189,000

Diphenoxylate ................................................................................................................................................................................... 1,600,000

Ecgonine ........................................................................................................................................................................................... 651,000

Ethylmorphine ................................................................................................................................................................................... 12

Fentanyl ............................................................................................................................................................................................ 202,000

Glutethimide ...................................................................................................................................................................................... 2

Hydrocodone (for sale) ..................................................................................................................................................................... 13,908,000

Hydrocodone (for conversion) .......................................................................................................................................................... 3,000,000

Hydromorphone ................................................................................................................................................................................ 766,000

Isomethadone ................................................................................................................................................................................... 12

Levo-alpha-acetylmethadol (LAAM) ................................................................................................................................................. 356,000

Levomethorphan ............................................................................................................................................................................... 2

Levorphanol ...................................................................................................................................................................................... 15,000

Meperidine ........................................................................................................................................................................................ 9,311,000

Methadone (for sale) ........................................................................................................................................................................ 3,790,000

Methadone (for conversion) .............................................................................................................................................................. 1,169,000

Methadone Intermediate ................................................................................................................................................................... 6,777,000

Methamphetamine (for conversion) .................................................................................................................................................. 723,000

Methylphenidate ................................................................................................................................................................................ 14,442,000

Morphine (for sale) ........................................................................................................................................................................... 11,535,000

Morphine (for conversion) ................................................................................................................................................................. 75,918,000

Nabilone ............................................................................................................................................................................................ 2

Noroxymorphone (for sale) ............................................................................................................................................................... 25,000

Noroxymorphone (for conversion) .................................................................................................................................................... 2,117,000

Opium ............................................................................................................................................................................................... 615,000

Oxycodone (for sale) ........................................................................................................................................................................ 9,032,000

Oxymorphone ................................................................................................................................................................................... 120,000

Pentobarbital ..................................................................................................................................................................................... 16,562,000

Phencyclidine .................................................................................................................................................................................... 60

Phenmetrazine .................................................................................................................................................................................. 2

Phenylacetone .................................................................................................................................................................................. 10

Secobarbital ...................................................................................................................................................................................... 301,000

Sufentanil .......................................................................................................................................................................................... 700

Thebaine ........................................................................................................................................................................................... 9,580,000

Dated: November 17, 1997.

James S. Milford,

Acting Deputy Administrator.

[FR Doc. 97–30651 Filed 11–20–97; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Federal Bureau of Investigation

Criminal Justice Information Services;

Agency Information Collection

Activities; Proposed Collection;

Comment Request

ACTION: Notice of information collection

under review: Supplementary homicide

report.

The proposed information collection

is published to obtain comments from

the public and affected agencies.

Comments are encouraged and will be

accepted until January 20, 1998.

Request written comments and

suggestions from the public and affected

agencies concerning the proposed

collection of information. Your

comments should address one or more

of the following four points:

(1) Evaluate whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information will have

practical utility;

(2) Evaluate the accuracy of the

agencies estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumptions used;

(3) Enhance the quality, utility and

clarity of the information to be

collected; and

(4) Minimize the burden of the

collection of information on those who

are to respond, including through the

use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology,

e.g., permitting electronic submission of

responses.

Comments and/or suggestions

regarding the item(s) contained in this

notice, especially regarding the

estimated public burden and associated

response time should be directed to SSA

Paul J. Gans (phone number and address